Electrospun materials bring a spark of hope to a cardiovascular landscape darkened by setbacks for reabsorbable stents.
Scientists in the United Kingdom are investigating the potential of a new regenerative and tissue engineering technique that could transform veins into arteries to improve the outcomes for patients undergoing heart bypass surgery.
Shielding cardiologists from harmful radiation is the goal for two systems capable of navigating the vascular highway.
A Spanish team has, for the first time, successfully placed a pulmonary valve using catheterisation through the hepatic vein in a paediatric patient. Specialists believe this type of intervention could become an interesting alternative when traditional access points are not available.
Which CRT patients can be ‘downgraded’ from a CRT-D device with defibrillator function to a CRT-P with just a pacemaker function? This, with two further current CRT issues – chronotropic incompetence and telemonitoring of CRT patients – featured prominently at the Europace-Cardiostim Congress in Vienna.
A formerly bitter competition between cardiology and cardiac surgery is increasingly replaced by constructive cooperation. The Austrian Society of Cardiology (ÖKG) even held its annual congress along with the Austrian Society of Thoracic and Cardiovascular Surgery this year.
Coronary angioplasty is arguably the most revolutionary breakthrough in the history of cardiology. While the technique is today performed on millions of patients worldwide, its origins can be traced back to Zurich, Switzerland, in the late 1970s.
A team from Michigan Medicine developed a health behavioral intervention called Reach Out including mobile-messaging components, which they plan to use throughout a trial.
In more than 21% of complex anatomical osteosynthesis procedures, an intraoperative improvement of the implant position or a revision of reduction has to be performed (Recum von, J. et al., Unfallchirurg 2012, 115:196-201, Die intraoperative 3D-C-Bogen-Anwendung. State of the art).
Unlike the USA, Italy, Germany or the Netherlands, Spain does not include hyperthermia in its national health catalogue. Worse, many non-medical centres are increasingly offering hyperthermia as an alternative treatment, a situation that infuriates Spanish oncologic radiotherapists.
Biotronik’s Home Monitoring is an award-winning remote cardiac monitoring system that automatically collects data from a patient’s cardiac device, enabling the physician to review cardiac function independently of in-office visits.
In a review of half a dozen published studies in which patients self-reported use of opioids prescribed to them after surgery, researchers at Johns Hopkins report that a substantial majority of patients used only some or none of the pills, and more than 90 percent failed to dispose of the leftovers in recommended ways.
Findings suggest that modifying the cell replication cycle could make combined therapies more successful.
Early-stage colon cancer patients could benefit in the future from specific genetic tests that forecast their prognosis and help them make the right decision regarding chemotherapy.
People who survive a stroke or a mini-stroke without early complications have an increased risk of death, another stroke or heart attack (myocardial infarction) for at least 5 years following the initial stroke, found a new study published in the Canadian Medical Association Journal.
Although dementia is most often seen in adults, childhood or adolescent dementia does occur. A team of researchers from the University of Würzburg believes that established therapeutic drugs might be effective against childhood dementia.
The fourth World Brain Day (July 22) revolves around stroke – how to detect it, how to prevent it, how to treat it. Raad Shakir, president of the World Federation of Neurology (WFN), seizes the opportunity to raise awareness about a disease that is becoming more common globally – but also preventable to a large extent.
Many children with autism spectrum disorder experience significant gastrointestinal issues, but the cause of these symptoms is unknown. Professionals in the medical community have suggested a potential link between diet and gastrointestinal issues related to autism. Now, researchers from the University of Missouri School of Medicine have found that diet is not a contributing factor in these…
An international research team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve-Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T-cells of the immune system to react against foreign antigens and cancer.
The EASY PULSE® is an unbelievably small and light mechanical chest compression device. Performing manual chest compressions well for an extended period of time is almost impossible. Not only is it physically demanding, but other actions, such as vital signs monitoring, are also required simultaneously. SCHILLER’s EASY PULSE® is the solution for more efficient resuscitation: this portable,…
The U.S. Food and Drug Administration has cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.
Surgeons at Johns Hopkins Medicine report that their first series of a minimally invasive procedure to treat chronic pancreas disease, known as severe pancreatitis, resulted in shorter hospital stays, less need for opioids and fewer complications, compared with standard surgical approaches.
The ADVIA Centaur® High-Sensitivity Troponin I (TNIH) assay* is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a…
Canadian researchers have invented an intraoperative probe that reliably detects multiple types of tumour cells.
IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces the release of myQA version 2017-001. This new version further enhances the integration of quality assurance across all QA applications, departments and people.
